Nuclear medicine
PET/CT, scintigraphy and selected radionuclide treatments. Diagnostic tracers and therapeutic radiopharmaceuticals have different purposes.
Treatments in this specialty
Procedure guides
Times are planning guides, not national averages or guaranteed schedules. They reflect published provider examples and patient guidance. The treating team confirms the individual plan, time needed near the clinic and fitness to travel. Waiting lists are not included.
FDG PET/CT
Imaging glucose metabolism in selected disease.
- Time
- NHS PET example: 30–60 minutes of scanning, with tracer preparation beforehand.
- Appointments
- 1 test attendance + results review
Can’t find your treatment?
Tell us the specialty or service you need. We can clarify the next coordination step.
Clinical terms
Use these clinical terms when discussing a referral or looking for a provider. Focused care areas may sit within a broader medical specialty.
- Nuclear medicine
- NuklearmedizinGermanNukleární medicínaCzech
Radiopharmaceutical eligibility, access and radiation-protection instructions are confirmed by the treating nuclear-medicine service.
Treatments & services
Explore specific procedures, investigations and care services. The clinical team confirms which options fit the individual case.
FDG PET/CT
Imaging glucose metabolism in selected disease.
PSMA PET/CT
Targeted imaging of selected prostate cancers.
Somatostatin-receptor PET/CT
Imaging selected neuroendocrine tumours.
Bone scintigraphy
Assessing skeletal tracer uptake.
Thyroid scintigraphy
Assessment of thyroid functional activity.
Parathyroid scintigraphy
Localisation of selected overactive glands.
Myocardial perfusion SPECT
Assessment of heart-muscle blood supply.
Ventilation–perfusion lung scan
Comparing lung airflow and blood flow.
MAG3 renography
Kidney drainage and relative function assessment.
DMSA renal scintigraphy
Assessment of renal cortical function and scarring.
Sentinel lymph-node scintigraphy
Identifying lymphatic drainage before surgery.
Gastric emptying scintigraphy
Measuring the rate of stomach emptying.
Dopamine transporter SPECT
Support for selected movement-disorder diagnosis.
MIBG scintigraphy
Imaging selected neuroendocrine tissue.
Radioiodine for hyperthyroidism
Treatment of selected overactive thyroid disease.
Radioiodine for thyroid cancer
Treatment of eligible differentiated thyroid cancer.
Lutetium-177 PSMA therapy
Radioligand treatment for eligible prostate cancer.
Lutetium-177 DOTATATE therapy
Receptor-targeted treatment for eligible neuroendocrine tumours.
Radium-223 therapy
Treatment for a defined prostate-cancer indication.
Radionuclide therapy dosimetry
Individual radiation-dose assessment.
Can’t find your treatment?
Tell us the specialty or service you need. We can clarify the next coordination step.
Planning your care
Ask the treating service for a written plan. Appointment numbers and time away depend on the procedure, results and individual needs.
- Does the team need pathology, staging or biomarker review before recommending treatment?
- Ask for a written calendar distinguishing treatment sessions or cycles, blood tests, review visits and possible inpatient care.
- Which symptoms need urgent attention, and who will provide support between treatments and after returning home?
Sources & availability
These references provide clinical background. The guide is not a confirmed service menu for every centre or both countries, and cited organisations are not necessarily RAUQ partners. Confirm eligibility, availability and international patient access with the centre.
Guide content and sources checked 29 October 2026.